---
title: "Jefferies Reaffirms Their Buy Rating on arGEN X (0QW0)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293709598.md"
description: "Jefferies analyst Akash Tewari reaffirmed a Buy rating on arGEN X (0QW0), with shares closing at €797.00. The stock holds a Strong Buy consensus with a price target of €902.17, implying 13.20% upside. Additionally, Barclays maintained a Buy rating today, setting a higher price target of €950.00."
datetime: "2026-07-24T06:06:38.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293709598.md)
  - [en](https://longbridge.com/en/news/293709598.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293709598.md)
generator: "portal-rs"
---

# Jefferies Reaffirms Their Buy Rating on arGEN X (0QW0)

In a report released yesterday, Akash Tewari from Jefferies maintained a Buy rating on arGEN X. The company’s shares closed yesterday at €797.00.

### Claim 55% Off TipRanks

-   Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
-   Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks

According to TipRanks, Tewari is a 5-star analyst with an average return of 13.3% and a 56.25% success rate. Tewari covers the Healthcare sector, focusing on stocks such as Eli Lilly & Co, Pfizer, and Ionis Pharmaceuticals.

arGEN X has an analyst consensus of Strong Buy, with a price target consensus of €902.17, a 13.20% upside from current levels. In a report released today, Barclays also maintained a Buy rating on the stock with a €950.00 price target.

### Related Stocks

- [ARGX.US](https://longbridge.com/en/quote/ARGX.US.md)
- [JEF.US](https://longbridge.com/en/quote/JEF.US.md)
- [LLY.US](https://longbridge.com/en/quote/LLY.US.md)
- [PFE.US](https://longbridge.com/en/quote/PFE.US.md)
- [IONS.US](https://longbridge.com/en/quote/IONS.US.md)
- [BCS.US](https://longbridge.com/en/quote/BCS.US.md)
- [BARC.UK](https://longbridge.com/en/quote/BARC.UK.md)

## Related News & Research

- [UBS Just Upgraded Argenx Stock. Here's Why.](https://longbridge.com/en/news/297084449.md)
- [Goldman Sachs Reaffirms Their Buy Rating on arGEN X (0QW0)](https://longbridge.com/en/news/297482774.md)
- [argenx to Present at Upcoming Investor Conferences | ARGX Stock News](https://longbridge.com/en/news/297598333.md)
- [RBC Capital Keeps Their Buy Rating on arGEN X (0QW0)](https://longbridge.com/en/news/296296197.md)
- [argenx completes acquisition of Forte Biosciences for $77 per share](https://longbridge.com/en/news/297189309.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**